drugset / Trial / NCT01206946

Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants

NCT01206946

Phase 2 Unknown 700 enrolled American University of Beirut Medical Center
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The hypothesis of the study is that administration of antenatal steroid to women at high risk of preterm birth after 34 weeks of gestation would reduce the risk of respiratory complications, specifically Respiratory Distress Syndrome (RDS) or Transient Tachypnea of the Newborn (TTN) in late preterm babies.

Timeline

Start
2010-09
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Betamethasone Other / unclassified 12 mg